What are the precautions with proton pump inhibitor use for reflux disease?

被引：2

作者：

Mospan, Cortney M. ^{[1
,2
]}

机构：

[1] E Tennessee State Univ, Bill Gatton Coll Pharm, Pharm Practice, Johnson City, TN 37614 USA

[2] Univ Charitable Pharm, Columbus, OH USA

来源：

JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS | 2015年 / 28卷 / 12期

关键词：

gastroesophageal reflux disease; proton pump inhibitor; comorbidities; older adults; clopidogrel; fractures; THERAPY; SAFETY;

D O I：

10.1097/01.JAA.0000473372.47749.16

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Gastroesophageal reflux disease (GERD) affects 10% to 20% of the western world's population. Current treatment guidelines recommend proton pump inhibitors (PPIs) as first-line therapy. Although PPIs cause mild adverse reactions, they pose risks, particularly for older adults with comorbidities.

引用

页码：23 / 26

页数：3

共 50 条

[41] The role of proton-pump inhibitor therapy in patients with gastroesophageal reflux disease and difficult-to-control asthma
Goh, Khean-Lee
Wong, Choon-Heng
EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (15) : 2015 - 2017
[42] Frequency scale for symptoms of gastroesophageal reflux disease questionnaire predicts requirement of proton pump inhibitor maintenance therapy
Masaki Miyamoto
Noriaki Manabe
Ken Haruma
Esophagus, 2010, 7 : 143 - 149
[43] Gastroesophageal reflux disease in primary care: Using changes in proton pump inhibitor therapy as an indicator of partial response
Ruigomez, Ana
Johansson, Saga
Wernersson, Boerje
Fernandez Cantero, Oscar
Garcia Rodriguez, Luis A.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2012, 47 (07) : 751 - 761
[44] Treatment of non-erosive reflux disease with a proton pump inhibitor in Chinese patients: a randomized controlled trial
Tan, Victoria P. Y.
Wong, Wai M.
Cheung, Ting K.
Lai, Kam C.
Hung, Ivan F. N.
Chan, Pierre
Pang, Roberta
Wong, Benjamin C. Y.
JOURNAL OF GASTROENTEROLOGY, 2011, 46 (07) : 906 - 912
[45] Positive predictors for gastroesophageal reflux disease and the therapeutic response to proton-pump inhibitors
Valentin Becker
Stefan Grotz
Christoph Schlag
Simon Nennstiel
Analena Beitz
Bernhard Haller
Roland M Schmid
Alexander Meining
Monther Bajbouj
World Journal of Gastroenterology, 2014, (14) : 4017 - 4024
[46] Efficacy of Proton-Pump Inhibitors in Children With Gastroesophageal Reflux Disease: A Systematic Review
van der Pol, Rachel J.
Smits, Marije J.
van Wijk, Michiel P.
Omari, Taher I.
Tabbers, Merit M.
Benninga, Marc A.
PEDIATRICS, 2011, 127 (05) : 925 - 935
[47] Positive predictors for gastroesophageal reflux disease and the therapeutic response to proton- pump inhibitors
Becker, Valentin
Grotz, Stefan
Schlag, Christoph
Nennstiel, Simon
Beitz, Analena
Haller, Bernhard
Schmid, Roland M.
Meining, Alexander
Bajbouj, Monther
WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (14) : 4017 - 4024
[48] INFLUENCE OF PROTON PUMP INHIBITOR USE IN GASTROINTESTINAL POLYPS
Hsu, Wen-Hung
Wu, I-Chen
Kuo, Chao-Hung
Su, Yu-Chung
Lu, Chien-Yu
Kuo, Fu-Chen
Jan, Chang-Ming
Wang, Wen-Ming
Wu, Deng-Chyang
Yu, Fang-Jung
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2010, 26 (02) : 76 - 83
[49] Effect of Proton Pump Inhibitor on the Outcome of Laryngeal Microsurgery in Patients With Vocal Fold Mucosal Disease With Reflux Symptoms
Bang, Je Ho
Lee, Sun Gyu
Kwon, Ki Jin
Lee, Seul Ah
Eun, Young-Gyu
Lee, Young Chan
JOURNAL OF VOICE, 2024, 38 (04) : 931 - 935
[50] Proton Pump Inhibitor Use, Hypergastrinemia, and Gastric Carcinoids-What Is the Relationship?
McCarthy, Denis M.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (02)

← 1 2 3 4 5 →